Dermato(poly)myositis in neoplastic disease

PheWeb

DERMATOPOLY_NEOPLASM

No definition available.

Endpoint definition

↥

FinnGen phenotype data

individuals

Apply sex-specific rule None

Check conditions None

Filter registries

Hospital Discharge: ICD-10 M36.0*

Hospital discharge: ICD-9 $!$

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 M36.0*

Cause of death: ICD-9 $!$

Cause of death: ICD-8 $!$

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

DERMATOPOLY_NEOPLASM

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Dermato(poly)myositis in neoplastic disease based on the number of shared cases.

Broader endpoints:

None

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	-	-	-
Unadjusted prevalence (%)	-	-	-
Mean age at first event (years)	-	-	-

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: DERMATOPOLY_NEOPLASM – Dermato(poly)myositis in neoplastic disease
GWS hits:

Survival analyses between endpoints

↥

Plot

before Dermato(poly)myositis in neoplastic disease
after Dermato(poly)myositis in neoplastic disease

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Dermato(poly)myositis in neoplastic disease

↥